Method and compositions for the treatment of thrombotic episodes

Details Method and compositions for the treatment of thrombotic episodes Method and compositions for the treatment of thrombotic episodes

1987-02-04

1988-12-13

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

424 9463, 514 17, A61K 3748

Patent

active

047909889

ABSTRACT:
Fibrinogen degradation product pentapeptide 6A and its variants are used in the treatment of thrombi, in particular myocardial infarcts. In a preferred embodiment pentapeptide 6A and tissue plasminogen activator are administered together to enhance the thrombolytic activity of tissue plasminogen activator.

REFERENCES:
patent: 4427646 (1984-01-01), Olexa et al.
patent: 4555290 (1984-06-01), Olexa et al.
patent: 4663146 (1987-05-01), Morser et al.
Thrombosis Research 30; 213-218, 1983, Andersson et al., American Physiological Society, pp. H457-H462, Mehta et al.
Biochimica et Biophysica Acta, 757(1983), pp. 366-370, Gerdin et al.
Prostaglandins Leukotrienes and Medicine 11, pp. 51-61, 1983, Hirose et al.
Prostaglandins Leukotrienes and Medicine 12j, 235-244, 1983, McDonald et al.
Chem. Abstracts, vol. 98, 1983, 193992e.
Chem. Abstracts, vol. 104, 1986, 101747v.
Chem. Abstracts, vol. 104, 1986, 45491t.
Chem. Abstracts, vol. 106, 1987, 38500h.
Biol. Abstracts, 73(6), 1982, 36910.

Affiliated with

Also associated with

Rating

Method and compositions for the treatment of thrombotic episodes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and compositions for the treatment of thrombotic episodes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions for the treatment of thrombotic episodes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2195517